MedPath

Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity

Not Applicable
Completed
Conditions
Aspirin Hypersensitivity
NSAIDs Hypersensitivity
Interventions
Procedure: Lysine-ASA Nasal ProvocationTest
Registration Number
NCT00815126
Lead Sponsor
Chulalongkorn University
Brief Summary

This study aims to compare the efficacy of nasal provocation test with Lysine-Acetylsalicylate in patients with history of NSAIDs hypersensitivity between mucocutaneous symptoms and respiratory symptoms and laboratory outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Patients with history of ASA/NSAIDs hypersensitivity with mucocutaneous symptoms and/or respiratory symptoms
Exclusion Criteria
  • Patients who cannot discontinue drugs before the test as follow

    • Nasal corticosteroids/Oral corticosteroids/Leukotriene modifiers for 1 week
    • Short-acting antihistamines for 3 days
    • Nasal a-mimetics/Oral a-mimetics/Local cromones for 24 hours
  • Contraindicated for nasal provocation test: pregnant, exacerbation of allergic rhinitis/asthma, having upper respiratory tract infection within 2 weeks prior to the test, having nose surgery within 8 weeks prior to the test, having severe systemic disease(s)

  • Having factors interfere nasal provocation test with Lysine-ASA such as massive nasal polyp, nasal septal perforation, total nasal obstruction at least 1 nostril

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mucocutaneous symptoms from NSAIDsLysine-ASA Nasal ProvocationTest-
Respiratory symptoms from NSAIDsLysine-ASA Nasal ProvocationTest-
NSAIDs tolerant individualsLysine-ASA Nasal ProvocationTest-
Primary Outcome Measures
NameTimeMethod
Symptom scores and/or acoustic rhinometry result upon Lysine-ASA nasal provocation test in patients with history of mucocutaneous or respiratory symptoms from NSAIDs5 months
Secondary Outcome Measures
NameTimeMethod
Correlation between clinical manifestations and laboratory results (basophil activation test, etc.)5 months

Trial Locations

Locations (1)

Faculty of Medicine, Chulalongkorn University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath